Stay updated on Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site display or release change without altering the study content.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded revision note v3.5.0 and removed revision note v3.4.3. The change does not modify the study details or page content.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded the 'Results Submitted' status and updated the page revision to v3.4.3, replacing the previous 'No Results Posted' status and v3.4.2.SummaryDifference0.1%

- Check59 days agoChange DetectedThe institution name was updated from Sidney Kimmel Cancer Center at Thomas Jefferson University to Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded revision note: v3.4.2. Removed prior funding-status notice and revision note v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.